Patients' Freedom to Choose Act

Outreach on patient access to vision care, H.R.605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care, H.R.605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Outreach on patient accessto vision care, H.R. 605/S.312. Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Outreach on patient access to vision care; H.R.605 / S. 312 Patients' Freedom to Choose Act; Physician Payment Reporting Requirements "Sunshine Act"; Customs and Trade Issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.

Client expense: Not reported · Firm income: Not reported

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to oral-health and dental practice in the following bills: H.R. 2/S. 192, Repealing the Job-Killing Health Care Law Act; H.R. 5/S. 218, S. 1099, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011;H.R. 38, A bill to rescind funds appropriated to the Health Insurance Reform Implementation Fund under the Health Care and Education Reconciliation Act of 2010; HR105, Empowering Patients First Act; HR157, Health Care Safety Net Enhancement Act of 2011; HR165, Informed Choice Act; H.R. 969, the Medical Practice Freedom Act of 2011; H.R. 314, Medical Liability Procedural Reform Act of 2011; H.R. 570, Dental Emergency Responder Act; H.R. 1578/S. 1765, Violence Against Women Health Initiative Act of 2011; H.R. 2119, Ryan Creedon Act of 2011; H.R. 2405/S. 1855, Pandemic and All Hazards Preparedness Act of 2011; H.R. 3586, Good Samaritan Health Professionals Act of 2011; S. 197, Medical Care Access Protection (MCAP) Act of 2011; S. 312/H.R. 605, Patients Freedom to Choose Act; S. 966, Bone Health Promotion and Research Act of 2011; S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act; S. 1878/H.R. 4091, Coordination of Pro Bono Medically Recommended Dental Care Act; S. 1925, Violence Against Women Reauthorization Act of 2011; H.R. 3765, Temporary Payroll Tax Cut Continuation Act of 2011; H.R. 3839, Drug Shortage Prevention Act of 2012; S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act; S. 3187 [H.R. 5651] - Prescription Drug User Fee Act. H.R. 5909 - Comprehensive Dental Reform Act of 2012 H.R. 5979 - Medicaid Accountability and Care Act of 2012 S. 3272 - Comprehensive Dental Reform Act of 2012 Community water fluoridation Medicaid and CHIP Payment and Access Commission: -Center for Consumer Information and Insurance Oversight; -Center for Medicaid, CHIP and Survey and Certification; Implementation of P.L. 111-148; 111-152, Patient Protection and Affordable Care Act; Oral-health issues within Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, Healthy People 2020; Comments on planning and establishment of state level exchanges; Office of the Assistant Secretary for Preparedness and Response, National Health Security Strategy (biennial implementation plan), National Disaster Medical System (disaster medical assistance team) regarding issues related to utlization of dental professionals in the event of a disaster; Office of Global Health (United Nations high-level meeting on non-communicable diseases); Division of Oral Health Reorganization; Limited English Proficiency Guidelines; Advisory Committee on Training in Primary Care Medicine and Dentistry Nominations, Ninth Report to Congress; National Advisory Dental and Craniofacial Research Council Nominations; Center for Substance Abuse Treatment, National Recovery Month; United Nations Summit on Non-Communicable Diseases; National Drug Control Strategy / Prescription Drug Abuse Prevention Plan; DEA National Prescription Drug Take Back Campaign; FDA Center for Drug Evaluation and Research regarding dry mouth labeling; Medical/Dental Coding Issues; Comparative Effectiveness regarding Dental Quality Alliance; Health Information Technology (HIT) Regulations; Health care issues before the Joint Select Committee on Deficit Reduction. United Nations General Assembly's High-level Meeting on Non-communicable Diseases CMS proposed rule on reporting and returning Medicare overpaymentsFood and Drug Administration Sedation Product Guidance Centers for Disease Control and Prevention recommendations for identification of persons with Hepatitis C (HCV) chronic infection H.R. 5711 - Access to Substance Abuse Treatment Act of 2012 Department of Health and Human Services media campaign to educate the public about the dangers of tobacco use

Client expense: $790,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Other), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Navy, Dept of, Occupational Safety & Health Administration (OSHA), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

HR 2: Repealing the Job Killing Health Care Law Act; HR 5: Protecting Access to Healthcare Act; HR 369: Health Savings and Affordability Act of 2011; HR 436: Protect Medical Innovation Act of 2011; HR 605: Patients Freedom to Choose Act; HR 1206: Access to Professional Health Insurance Advisors Act; HR 1580: Medicare Beneficary Preservation of Choice Act of 2011; HR 1744: American Job Protection Act; HR 2010: Family and Retirement Health Investment Act of 2011;

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

Various issues related to the Patient Protection and Affordable Care Act (P.L. 111-148) and Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 1744/S. 20 employer mandate repeal; H.R. 1063/S. 1718 Medicare Secondary Payer reform; H.R. 2206 auto enrollment repeal; consumer directed health products; H.R. 436; H.R. 5842; H.R. 2529; H.R. 1004; H.R. 5858; H.R. 2010; S. 1098; S. 1368; H.R. 605; S. 312; H.R. 450

Client expense: $1,060,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Equal Employment Opportunity Commission (EEOC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Outreach on patient access to vision care, H.R. 605/S.312 Patients Freedom to Choose Act, Physician Payment Reporting Requirements "Sunshine Act", customs and trade issues

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, U.S. Trade Representative (USTR)

H.R. 1409: All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274: All provisions of the Medication Therapy Management Benefits Act of 2011; H.R. 905 /S. 733:All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare H.R. 979 - All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 605 / S. 312 -All provisions of the Patients Freedom to Choose Act S. 27 - All provisions of the Preserve Access to Affordable Generics Act S. 31 - All provisions of the Prescription Drug and Health Improvement Act of 2011 S. 44 -All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011 H.R. 999 / S. 560 - All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011 H.R. 1839 - All provisions of the Community Pharmacy Fairness Act of 2011; H.R. 1946 - All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011; H.R. 1971 / S. 1058 - All provisions of the Pharmacy Competition and Consumer Choice Act of 2011 Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio) Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of approval pathway for generic biologic drugs 340b program H.R. 2672 the Preserving Access to Orphan Drugs Act H.R. 2182 the Generating Antibiotic Incentives Now Act H.R. 3026 the Safeguarding Americas Pharmaceuticals Act H.R. 2746 the Cancer Drug Coverage Parity Act H.R.4215 - All provisions of the Medicare Pharmacy Transparency and Fair Auditing Act

Client expense: $559,998 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE

H.R. 5: All provisions of the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011; H.R. 1409: All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274: All provisions of the Medication Therapy Management Benefits Act of 2011; H.R. 905 /S. 733: All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; H.R. 979 - All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 4 /S.18 / S.72 - All provisions of the Small Business Paperwork Mandate Elimination Act H.R. 605 / S. 312 - All provisions of the Patients Freedom to Choose Act S. 27 - All provisions of the Preserve Access to Affordable Generics Act S. 31 - All provisions of the Prescription Drug and Health Improvement Act of 2011 S. 44 - All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011 H.R. 999 / S. 560 - All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011 H.R. 1839 - All provisions of the Community Pharmacy Fairness Act of 2011; H.R. 1946 - All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011; H.R. 1971 / S. 1058 - All provisions of the Pharmacy Competition and Consumer Choice Act of 2011 Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio) Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs Regulatory Implementation of the HITECH Act FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs), implementation of approval pathway for generic biologic drugs 340b program H.R. 2245/S. 296 - All provisions of the Preserving Access to Life-Saving Medications Act of 2011

Client expense: $559,998 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE

Monitor legislation and federal issues related to Association Health Plans, Small Business Health Plans, Health-Care Related Tax Credits, Health Savings Accounts and Flexible Spending Accounts. Monitor legislation and federal issues related to uniform application of ERISA mandates. Monitor legislation and federal issues related to Workforce Training. Monitor the implementation of the Affordable Health Care for America Act, (P.L. 111-192). Monitor the implementation of the Patient Protection and Affordable Care Act, (P.L. 111-148). Monitor the implementation of the Healthcare and Education Reconciliation Act of 2010, (P.L. 111-152). Section 1251 and 10103 of the Patient Protection and Affordable Care Act (P.L. 111-148) regarding grandfathered status-Enzi Amendment to the Defense Authorization Act for fiscal year 2011 (S.3454) 111th Congress. Interim Final Rule regarding requirements for group health plans and health insurance issues for preexisting condition exclusions, lifetime and annual limits, rescissions, and patient protections. Labor: RIN-1210-AB43, HHS: OCIIO 9994-IFC, IRS: REG-120399-10. Subregulatory guidance for OCIIO Sub-Regulatory Guidance (OOIIO 2010-1): Process for Obtaining Waivers of the Annual Limits Requirements of the Public Health Service Act Section 2711. Request for comments regarding the planning and establishment of the state-level exchanges HHS:OC110-9989-NC. H.R. 2, Repealing the Job-Killing Health Care Law Act. H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011. H.R. 984, Health Care Waiver Fairness Act of 2011. H.Res. 9, Instructing certain committees to report legislation replacing the job-killing health care law. S. 20, American Job Protection Act. H.R. 1744, American Job Protection Act. H.R. 2206, Auto Enroll Repeal Act. H.R. 1370, To repeal the annual fee on health insurance providers enacted in the Patient Protection and Affordable Care Act. S. 1880, To repeal the annual fee on health insurance providers enacted in the Patient Protection and Affordable Care Act. S. 1049, Small Business Health Relief Act of 2011. IRS Notice 2011-36, Request for comments on Shared Responsibility For Employers Regarding Health Coverage (Section 4980H). Proposed Rule, Patient Protection and Affordable Care Act; Establisment of Exchanges Qualified Health Plans (RIN-0938-AQ67). Proposed Rule, Patient Protection and Affordable Care Act; Exchange Functions in the Individual Market: Eligibility Determinations; Exchange Standards for Employers (RIN-0938-AR25). Notice of Proposed Rulemaking: Summary of Benefits and Coverage and the Uniform Glossary (CMS - 9982 - P). Proposed Rule: Patient Protection and Affordable Care Act; Exchange Functions in the Individual Market: Eligibility Determinations; Exchange Standards for Employers (CMS - 9974 - P). Proposed Rule: Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans (CMS - 9989 - P). Final Rule with Comment Period: Medical Loss Ratio Requirments Under Patient Protection and Affordable Care Act (CMS - 9998 - FC) RN: 0938 -AQ71. H.R. 1173, Fiscal Responsibilty and Retirement Security Act of 2011. S. 720, Repeal the CLASS Entitlement Act. S. 312, Patients' Freedom to Choose Act. H.R. 605, Patients' Freedom to Choose Act. H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act of 2011. Notice 2012-17 Frequently Asked Questions From Employers Regarding Automatic Enrollment, Employer Shared Responsibility, and Waiting Periods. Final Rule: Summary of Benefits and Coverage and Uniform Glossary. (RIN 0938 - AQ73) Essential Benefits Bulletin Bulletin: Verification of Access to Employer-Sponsored Coverage Bulletin. H.R. 436, Heath Care Cost Reduction Act of 2012. Notice 2012-59: Guidance on 90-day Waiting Period Limitation Under Public Health Service Act. H.R. 6174, Common Sense Nutrition Disclosure Act. S. 3574, Common Sense Nutrition Disclosure Act.

Client expense: $493,111 · Firm income: Not reported

Government targets: Administration on Aging, Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Office of Management & Budget (OMB), SENATE, White House Office

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act, H.R. 1406.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.369, Health Savings and Affordability Act (Austria) - HSA improvements, H.R. 436, Health Care Cost Reduction Act (Paulsen) - HSA, HRA, FSA provisions, ACA provisions, H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act (Reichert) - repeal of HSA and FSA restrictions, H.R. 524, Restoring Consumer-driven Health Care Act (Quayle) - repeal of HSA restrictions, H.R. 605, Patients' Freedom to Choose Act (Paulsen) - repeal of HSA and FSA restrictions, H.R. 1004, Health Flexible Spending Arrangements Improvements Act (Boustany) -- distribution of unused amounts from a Health FSA, H.R. 1370, Repeal of ACA Premium Tax (Boustany), H.R. 2010, Family and Retirement Health Investment Act (Paulsen) - HSA and FSA improvements, H.R. 2529, Restoring Access to Medication Act (Jenkins) - use of HSA funds and FSA funds to purchase OTC medications, H.R. 5842, Restoring Access to Medication Act (Jenkins) - use of HSA, HRA, and FSA funds for over-the-counter medications, H.R. 5858, Health Savings Accounts Improvements Act (Herger) - HSA provisions, H.R. 6005, Long-Term Care and Retirement Security Act (Courtney) - tax incentives for purchase of LTC insurance, consumer protections, H.R. 6088, Repeal of the Unfair Taxes on Health Care Act (Schweikert) - repeal of ACA premium tax and restrictions on HSAs / FSAs, H.R. 6137, Helping Save Americans' Health Care Choices Act (Fleming) - HSA and FSA provisions, H.R. 6162, Ensuring Women's Access to Free-Market Healthcare Act (Cassidy) - pregnancy-related coverage by HSA plans, S. 312, Patients' Freedom to Choose Act (Hutchison) - repeal of HSA and FSA restrictions, S. 1098, Family and Retirement Health Investment Act (Hatch) - HSA and FSA improvements, S. 1368, Restoring Access to Medication Act (Roberts) - use of HSA funds and FSA funds to purchase OTC medications, S. 1880, Jobs and Premium Protection Act (Barrasso) - repeal of health insurance premium tax, S. 2237, Small Business Jobs and Tax Relief Act (Reid) - amendment to repeal ACA premium tax, S. 2516, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues, S. 3187, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Flexible spending arrangements (FSA) and health savings accounts (HSA) H.R. 2529/S. 1368 - Restoring Access to Medication Act. Repeals prohibition in Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) against use of flexible spending arrangement (FSA) and health savings account (HSA) funds on over-the-counter medications; all sections. H.R. 2529 reintroduced as H.R. 5842, then included in House consideration and approval of H.R. 436 - Health Care Cost Reduction Act; Section 3. H.R. 605/S. 312 - Patients' Freedom to Choose Act. Repeals prohibition in Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) against use of flexible spending arrangement (FSA) and health savings account (HSA) funds on over-the-counter medications; all sections. H.R. 2010/S. 1098 - Family and Retirement Health Investment Act of 2011. Repeals prohibition in Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) against use of flexible spending arrangement (FSA) and health savings account (HSA) funds on over-the-counter medications; all sections.

Client expense: $170,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

H.R.369, Health Savings and Affordability Act (Austria) HSA improvements 16. Specific Lobbying Issues (continued): H.R. 436, Health Care Cost Reduction Act (Paulsen) HSA, HRA, FSA provisions, ACA provisions H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act (Reichert) repeal of HSA and FSA restrictions H.R. 524, Restoring Consumer-driven Health Care Act (Quayle) repeal of HSA restrictions H.R. 605, Patients' Freedom to Choose Act (Paulsen) repeal of HSA and FSA restrictions H.R. 1004, Health Flexible Spending Arrangements Improvements Act (Boustany) -- distribution of unused amounts from a Health FSA H.R. 1370, Repeal of ACA Premium Tax (Boustany) H.R. 2010, Family and Retirement Health Investment Act (Paulsen) HSA and FSA improvements H.R. 2529, Restoring Access to Medication Act (Jenkins) use of HSA funds and FSA funds to purchase OTC medications H.R. 5842, Restoring Access to Medication Act (Jenkins) use of HSA, HRA, and FSA funds for over-the-counter medications H.R. 5858, Health Savings Accounts Improvements Act (Herger) HSA provisions H.R. 6005, Long-Term Care and Retirement Security Act (Courtney) tax incentives for purchase of LTC insurance, consumer protections H.R. 6088, Repeal of the Unfair Taxes on Health Care Act (Schweikert) repeal of ACA premium tax and restrictions on HSAs / FSAs H.R. 6137, Helping Save Americans' Health Care Choices Act (Fleming) HSA and FSA provisions H.R. 6162, Ensuring Women's Access to Free-Market Healthcare Act (Cassidy) pregnancy-related coverage by HSA plans S. 312, Patients' Freedom to Choose Act (Hutchison) repeal of HSA and FSA restrictions S. 1098, Family and Retirement Health Investment Act (Hatch) HSA and FSA improvements S. 1368, Restoring Access to Medication Act (Roberts) use of HSA funds and FSA funds to purchase OTC medications S. 1880, Jobs and Premium Protection Act (Barrasso) repeal of health insurance premium tax S. 2237, Small Business Jobs and Tax Relief Act (Reid) amendment to repeal ACA premium tax S. 2516, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues S. 3187, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues Regulatory Issues: Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate, W-2 reporting requirements, health insurer fee, and other issues relating to health care reform implementation.

Client expense: $2,020,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Pension & Welfare Benefits Administration, SENATE, Treasury, Dept of, White House Office

See Addendum Implementing Regulations for Public Law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003, Title XII, Section 1201, Health Savings Accounts. Implementing Regulations for Public Law 111-148, The Patient Protection and Affordable Care Act of 2010, All Sections, but especially regulations pertaining to the Medical Loss Ratio and Actuarial Value calculations. Implementing Regulations for Public Law 111-517, Dodd-Frank Wall Street Reform and Consumer Protection Act, All Sections, but in particular, implementation of the Federal Insurance Office and the Bureau of Consumer Financial Protection; Credit Insurance; Truth in Lending Disclosures, Debt Protection Products Education of Members of Congress on the workings of the Health Savings Account industry including presentations on the establishment of the account, the coordination of the account with the qualifying insurance policy, and a comparison of HSAs to other health care financing strategies. Comments submitted on membership of the Federal Home Loan Bank, 12 CFR 1263 Optional Federal Regulation of Insurance H.R. 605/S. 312, the Patients Freedom to Choose Act of 2011 H.R. 1112/S.2342, the National Association of Registered Agents and Brokers Reform Act of 2011 H.R. 1206, the Access to Professional Health Insurance Advisors Act of 2011 H.R. 1309, the Flood Insurance Reform Act of 2011 H.R. 2010/S. 1098, the Family and Retirement Health Investment Act of 2011

Client expense: $70,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of

See Addendum Implementing Regulation for Public Law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003, Title XII, Section 1201, Health Savings Accounts. Implementing Regulation for Public Law 11-148, The Patient Protection and Affordable Care Act of 2010, All Sections, but especially comments on the Medical Loss Ratio and Actuarial Value regulations. Implementing Regulations for Public Law 111-517, Dodd-Frank Wall Street Reform and Consumer Protection Act, All Sections. Education of Members of Congress on the workings of the Health Savings Account industry including presentations on the establishment of the account, the coordination of the account with the qualifying insurance policy, and a comparison of HSAs to other health care financing strategies. Optional Federal Regulation of Insurance H.R. 605/S. 312, the Patients Freedom to Choose Act of 2011 H.R. 1112/S.2342, the National Association of Registered Agents and Brokers Reform Act of 2011 H.R. 1206, the Access to Professional Health Insurance Advisors Act of 2011 H.R. 1309, the Flood Insurance Reform Act of 2011 H.R. 2010/S. 1098, the Family and Retirement Health Investment Act of 2011

Client expense: $70,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of

H.R. 397: Reform Americans Can Afford Act of 2011 High cost plan tax, employer provisions. H.R. 436: Health Care Cost Reduction Act of 2012 Repeal $2500 FSA limit. H.R. 605: Patients' Freedom to Choose Act (Sec. 1-3, repeal restrictions on Health Savings Accounts, Medicare Set Asides and Health Flexible Spending Arrangements enacted in Affordable Care Act.) H.R. 2010, S. 1098: Family and Retirement Health Investment Act of 2011 (Title 1, to repeal limits/caps on tax preferred health accounts.) S. 244: State Health Care Choice Act To prevent Employee Retirement Income Security Act (ERISA) from being waived. S. 248: Empowering States to Innovate Act To prevent Employee Retirement Income Security Act (ERISA) from being waived. S. 312: Patients' Freedom to Choose Act Sec. 1-3, repeal restrictions on Health Savings Accounts, Medicare Set Asides and Health Flexible Spending Arrangements enacted in Affordable Care Act.

Client expense: $590,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions. - Issues related to Ways and Means tax reform discussion draft. - HR 2735, "To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations", regarding all provisions. - S 1577, "Greater Research Opportunities With Tax Help Act", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - HR 1864, "Mobile Workforce State Income Tax Simplification Act of 2011", regarding all provisions. - S 2091, "United States Job Creation and International Tax Reform Act of 2012", regarding all provisions.

Client expense: $880,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)